Cllovemed Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 162.90%
- Profit Growth 46.20%
- Ebitda 58.17%
- Net Worth 3.31%
- Total Assets 1169.80%
About Cllovemed Pharma
Cllovemed Pharma Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 May 2018 (Six years and eight months 27 days old ). Its registered office is in Solan, Himachal Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shubham Singh, Suman Pathania, and Sampat Kumar serve as directors at the Company.
Company Details
-
Location
Solan, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999HP2018PTC007007
-
Company No.
007007
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
09 May 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
What products or services does Cllovemed Pharma Private Limited offer?
Cllovemed Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Pain Relief Drugs & Pharmaceuticals, Diclofenac, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Cllovemed Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Singh
|
Director | 29-Mar-2023 | Current |
|
Suman Pathania
|
Director | 27-Feb-2023 | Current |
|
Sampat Kumar
|
Director | 27-Feb-2023 | Current |
Financial Performance of Cllovemed Pharma.
Cllovemed Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 162.9% increase. The company also saw a substantial improvement in profitability, with a 46.2% increase in profit. The company's net worth moved up by a moderate rise of 3.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cllovemed Pharma?
Unlock access to Cllovemed Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cllovemed Pharma?
Unlock and access historical data on people associated with Cllovemed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cllovemed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cllovemed Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
